Table VI.
PROBIOTICS AS THERAPEUTIC APPROACH FOR AGING, STROKE, AND AD.
| Disease | Study title | Treatment | Reference |
|---|---|---|---|
| Aging | Lactobacillus Sp. Improved Microbiota And Metabolite Profiles Of Aging Rats | Probiotics | (161) |
| Aging | The Molecular Mechanisms Of Probiotic Strains In Improving Aging Bone And Muscle Of D-Galactose-Induced Aging Rats | Probiotics | (168) |
| Aging | Lactobacillus Fermentum JX306 Restrain D-Galactose-Induced Oxidative Stress Of Mice Through Its Antioxidant Activity | Probiotics | (160) |
| Aging | A Human-Origin Probiotic Cocktail Ameliorates Aging-Related Leaky Gut And Inflammation Via Modulating The Microbiota/Taurine/Tight Junction Axis | Probiotics | (104) |
| Aging | Probiotics And Prebiotics As A Therapeutic Strategy To Improve Memory In A Model Of Middle-Aged Rats | Probiotics | (164) |
| Aging | Longevity In Mice Is Promoted By Probiotic-Induced Suppression Of Colonic Senescence Dependent On Upregulation Of Gut Bacterial Polyamine Production | Probiotics | (198) |
| Stroke | Association Of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide With First Ischemic Stroke | Probiotics | (199) |
| Stroke | Clostridium Butyricum Pretreatment Attenuates Cerebral Ischemia/Reperfusion Injury In Mice Via Anti-Oxidation And Anti-Apoptosis | Probiotics | (141) |
| Stroke | Dysbiosis Of Gut Microbiota And Short-Chain Fatty Acids In Acute Ischemic Stroke And The Subsequent Risk For Poor Functional Outcomes | Probiotics | (200) |
| Stroke | Effects Of The Oral Ingestion Of Probiotics On Brain Damage In A Transient Model Of Focal Cerebral Ischemia In Mice | Probiotics | (140) |
| Stroke | Gut Microbiota-Derived Short-Chain Fatty Acids Promote Post-Stroke Recovery In Aged Mice | Probiotics | (8) |
| Stroke | Short-Chain Fatty Acids Improve Post-Stroke Recovery Via Immunological Mechanisms | Probiotics | (201) |
| Alzheimer’s | Effects Of Probiotic Supplementation On Short Chain Fatty Acids In The Appnl-G-F Mouse Model Of Alzheimer’s Disease | Probiotics | (202) |
| Alzheimer’s | Probiotics Ameliorate Intestinal Pathophysiology In A Mouse Model Of Alzheimer’s Disease | Probiotics | (203) |
| Alzheimer’s | Probiotics Ameliorate Intestinal Pathophysiology In A Mouse Model Of Alzheimer’s Disease. | Probiotics | (203) |
| Alzheimer’s | Probiotics Modulate The Microbiota-Gut-Brain Axis And Improve Memory Deficits In Aged SAMP8 Mice | Probiotics | (204) |
| Alzheimer’s | Short-Chain Fatty Acids: Microbial Metabolites That Alleviate Stress-Induced Brain-Gut Axis Alterations | Probiotics | (205) |